Otros idiomas Spago Nanomedical AB

Acciones

SPAGO

SE0004899474

Mercado cerrado - Nasdaq Stockholm Otros sitios de cotización 15:29:32 10/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,299 ^SEK	+5,65 %		-12,32 %	-8,56 %

24/04	Spago Nanomedical AB (publ) comunica datos favorables en un modelo de cáncer de mama con Tumorad	CI
16/04	Spago Nanomedical AB (publ) anuncia el nombramiento de Birgitta Rembratt Svensson como Directora de CMC & Supply, con efecto a partir del 1 de junio de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

BioStock: Spago's CEO - "Advancing the Tumorad programme comes first"	07/05
NOTICE TO ANNUAL GENERAL MEETING OF SPAGO NANOMEDICAL AB (PUBL)	06/05
Spago Nanomedical update after Q1 - Timely progress	03/05
Spago Nanomedical : Interim ReportQ12024	02/05
Spago Nanomedical interim report January-March 2024	02/05
Spago Nanomedical AB Reports Favorable Data in Breast Cancer Model with Tumorad	24/04
Spago Nanomedical reports favorable data in breast cancer model with Tumorad	24/04
Spago Nanomedical strengthens management with Head of CMC and Supply	17/04
Spago Nanomedical strengthens management with Head of CMC & Supply	16/04
Spago Nanomedical AB Announces Appointment of Birgitta Rembratt Svensson as Head of CMC & Supply, Effective June 1, 2024	16/04
BioStock: Spago Nanomedical's CEO: "huge commercial opportunities are unfolding"	27/03
BioStock: 2023 springboard for Spago's radionuclide cancer therapy	09/02
Spago Nanomedical Q4 Update	08/02
Spago Nanomedical year-end report January-December, 2023	07/02
Spago Nanomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023	07/02
Spago Nanomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07/02
The rights issue and the directed share issue to certain guarantors in Spago Nanomedical fully registered	25/01
Spago Nanomedical presents at Redeye's Fight Cancer event on January 24	19/01
Spago Nanomedical presents at Redeye’s Fight Cancer event on January 24	18/01
BioStock: Spago's phase I/IIa cancer trial progressing steadily	15/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Spago Nanomedical AB

Acciones

SPAGO

SE0004899474

Otros idiomas

Filtros